Catching the Therapeutic Window of Opportunity in Early Crohn’s Disease

E-ISSN： 1873-5592|15|11|1056-1063

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.11, 2014-10, pp. : 1056-1063

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maintenance of Remission in Crohns Disease: Current and Emerging Therapeutic Options

By Brookes M.J. Green J.R.B.

Drugs, Vol. 64, Iss. 10, 2004-01 ,pp. : 1069-1089

Adis International

Access to resources Recommend Favorite

Therapy of Crohn’s disease in childhood

By Beattie R Mark Bremner A Ronald F

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 809-825

Informa Healthcare

Access to resources Recommend Favorite

TNF- antagonists for the treatment of Crohn’s disease

By Kam L.Y. Targan S.R.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 615-622

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of infliximab in the course of treatment of Crohn’s disease

By Bratcher Jason M Korelitz Burton I

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 9-16

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in the pharmacological treatment of Crohn’s disease

By Srinivasan Radhika Lichtenstein Gary R

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 373-391

Informa Healthcare

Access to resources Recommend Favorite